Unknown

Dataset Information

Altered pharmacology of native rodent spinal cord TRPV1 after phosphorylation.


ABSTRACT:

Background and purpose

Evidence suggests that phosphorylation of TRPV1 is an important component underlying its aberrant activation in pathological pain states. To date, the detailed pharmacology of diverse TRPV1 receptor agonists and antagonists has yet to be reported for native TRPV1 under phosphorylating conditions. Our goal was to optimize a relatively high-throughput methodology to allow pharmacological characterization of the native TRPV1 receptor using a spinal cord neuropeptide release assay under naive and phosphorylating states.

Experimental approach

Herein, we describe characterization of rodent TRPV1 by measurement of CGRP release from acutely isolated lumbar (L1-L6) spinal cord using a 96-well technique that combines use of native, adult tissue with quantitation

SUBMITTER: Mogg AJ 

PROVIDER: S-EPMC3631388 | biostudies-literature | 2013 Feb

REPOSITORIES: biostudies-literature